NIH Funding Opportunities Drug Repurposing

NIH Cuts to University Research Funding

Cutting NIH funding puts my life on the line — and maybe yours as well

Private investment in pharmaceutical research can't replace the NIH. Both public investment and the private sector are needed to be world leaders in health care, writes Michelle Francl-Donnay.

USA Today · 2d

University of Iowa could miss out on $33.4M in research funding if NIH cuts are approved

The University of Iowa is in danger of losing out on $33.4 million in research funding if National Institutes of Health funding cuts are approved.

WPRI Providence on MSN · 1d

URI warns microplastics research could be at risk if NIH funding cut approved

Neuroscience Professor Jaime Ross has been studying the effects of microplastics on the brains of mice. In 2023, she told 12 News she had found a disturbing result: microplastics had managed to get past the blood-brain barrier.

Yale Daily News3d

ANALYSIS: NIH funding cuts threaten biotech, innovation and economy

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...

2don MSN

North Texas patients, researchers, institutions anxiously await end game of NIH funding cuts

The National Institutes of Health proposal would limit indirect costs for research projects to 15 percent of grants.

Opinion

The Journal News on MSN3dOpinion

NIH cuts to biomedical research funding will devastate NY's economy | Opinion

We urge the NIH to honor its current funding commitments. The future of American biomedical research is too important to do anything less.

StamfordAdvocate5d

Trump policy is putting $150 million in Connecticut research funding in limbo

At Yale, several individual projects received more than $10 million in NIH funding in 2024, including research into psychosis, drug abuse and neurogenetic disorders.

WBEZ5d

Illinois joins nearly two dozen states suing Trump administration to halt cuts in medical research funding

The University of Illinois system relies on about $67 million in NIH funding annually — dollars that last year helped develop an updated drug to treat blood cancer in children, Raoul said.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results